MedTrace Logo

Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA)

NCT04355338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3520

Last updated 2025-02-06

No results posted yet for this study

Summary

This is an observational study, meaning that no interventions is tested, to determine incidence of SARS-CoV-2 infection and COVID-19 in different clinical sites in Brazil in several age groups. The study aims to assess baseline number of infected participants and perform a follow-up along two years to determine the new cases occurring among participants during the period. All participants will collect blood samples to get more details on the immune response.

Conditions

Sponsors & Collaborators

  • Butantan Institute

    lead OTHER_GOV

Principal Investigators

  • Fernanda Boulos, MD, PhD · Butantan Institute

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-25
Primary Completion
2021-10-30
Completion
2024-10-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04355338 on ClinicalTrials.gov